Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Deloitte

This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.

Pfizer appoints David Denton as chief financial officer and executive vice president

Pfizer appoints David Denton as chief financial officer and executive vice president

Denton has held various leadership roles, including senior vice president and controller/chief accounting officer and has previously worked with the management consulting firm of Deloitte Touche Tohmatsu.

Latest news

  • The forefront of technology innovation The forefront of technology innovation

    These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November

  • Orphan drugs dominate FDA's record-breaking year Orphan drugs dominate FDA's record-breaking year

    A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.

  • Pharma’s R&D productivity sinks to a new low Pharma’s R&D productivity sinks to a new low

    The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study

  • NHS bracing for 'no deal’ Brexit impact, including medicines NHS bracing for 'no deal’ Brexit impact, including medicines

    According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Mind the gap: are digital health solutions really patient centric? Mind the gap: are digital health solutions really patient centric?

    According to the Deloitte Center for Health Solutions, interviews held with technology executives and leaders of healthcare systems evidenced the belief that digital transformation initiatives are mainly consumer-centric, with 92%

  • Life sciences reimagined Life sciences reimagined

    The author works within the broader life sciences/risk division of Deloitte in the Netherlands and this article combines the latest opinions and insights from across that team. ... Frits Stulp is managing director of Iperion, a Deloitte business, visit

  • Building a brighter future with patient support programmes Building a brighter future with patient support programmes

    Reports by analysts Deloitte underscore the value of PSPs as industry pivots to outcomes- based reimbursement models and emphasise the potential from AI, analytics and data.

  • Product launches: making the most of your one shot Product launches: making the most of your one shot

    A recent analysis by Deloitte showed that most new drugs continue with the revenue trajectory set at launch – around 70% of products that miss expectations at launch continue doing so in

  • The new reality of building a corporate brand in pharma The new reality of building a corporate brand in pharma

    According to Deloitte Insight’s 2021 Global Marketing Trends report, purpose is one of the key aspects necessary for businesses to flourish – they need to understand why they exist and who ... According to a 2019/20 Deloitte survey, 68% of biopharma

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • There's power in collaboration There's power in collaboration

    So prevalent are these issues, that one Deloitte industry study found that more than 57% of surveyed healthcare professionals could recall a time when a physician didn’t have the product ... By Asma Shirazi, Page &Page and Partners.

  • Genesis Research Acquires Market Access Transformation Genesis Research Acquires Market Access Transformation

    Advisors. Genesis Research was advised on the transaction by Clearview Healthcare Partners, Deloitte, Palo Alto, Piper Sandler and Ropes &Gray.

  • GHO Capital Acquires Genesis Research GHO Capital Acquires Genesis Research

    Ropes &Gray acted as legal advisor to GHO; CIL as commercial advisor; Alvarez and Marsal as financial advisor; Deloitte LLP as tax advisor and CRS as insurance advisor.

  • Remote Patient Monitoring

    The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM). With the onset of lockdown, and a sense of unease when visiting conventional clinical settings,

  • Impetus Digital Fireside Chat with Deloitte Europe: The Future of Learning

    Ladana Edwards, Partner at  Deloitte Central Europe and  Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as

More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Actinic keratosis – a common skin condition that can lead to skin cancer
PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...

Quick links